BackAngiodynamic Overview
Angiodynamic Inc

Angiodynamic Target Price

Analysts' average 12-month price target for Angiodynamic is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.04

Average Target Price

$19.5029.7% upside

2 analysts in the last 4 months

High: $20 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15H.C. WainwrightYi Chen$1926.3% upsideOpen
2026-07-15Canaccord Genuity$2033% upsideOpen
2025-10-03Canaccord Genuity$1819.7% upsideOpen
2025-07-16Canaccord GenuityJohn Young$1713% upsideOpen
2024-10-04Canaccord GenuityWilliam Plovanic$1220.2% downsideOpen
2024-09-20H.C. WainwrightYi Chen$146.9% downsideOpen
2024-04-05OppenheimerSteven Lichtman$1220.2% downsideOpen
2023-01-06Raymond James$2246.3% upsideOpen
2022-07-13Raymond James$2779.5% upsideOpen

Angiodynamic (ANGO) FAQ

Angiodynamic's target price stands at $20. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $20 for ANGO implies 29.7% upside versus today's price ($15.04). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Angiodynamic's target price evolved across reporting periods, while the comparison chart places ANGO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Angiodynamic's reading of $20 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.